Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 9/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.36 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3140434 | 0.80 | NISCH (0.36) | MEN1KMT2ALMNAPOLBCYP2C19 | |
| SCHEMBL30362056 | 0.80 | CYP19A1 (0.53) | MEN1KMT2ALMNAPOLBCYP19A1 | |
| SCHEMBL11883260 | 0.80 | CYP19A1 (0.53) | MEN1KMT2ALMNAPOLBCYP19A1 | |
| SCHEMBL28442693 | 0.79 | NISCH (0.35) | MEN1KMT2ALMNAPOLBNISCH | |
| SCHEMBL25015609 | 0.79 | CYP19A1 (0.43) | MEN1KMT2ALMNAPOLBCYP2C19 | |
| SCHEMBL11547380 | 0.79 | SIRT1 (0.39) | MEN1KMT2ALMNAPOLBCYP2C19 | |
| SCHEMBL4013126 | 0.79 | MEN1 (0.36) | MEN1KMT2ALMNAPOLBCYP2C19 | |
| SCHEMBL2269003 | 0.79 | CYP19A1 (0.47) | MEN1KMT2ACYP19A1ARMAOB | |
| SCHEMBL21347859 | 0.79 | MEN1 (0.47) | MEN1KMT2ALMNAPOLBCYP2C19 | |
| SCHEMBL30362163 | 0.79 | CYP19A1 (0.43) | MEN1KMT2ALMNAPOLBCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720136-A2 | LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR | RxSight, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| WO-2024249726-A2 | LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR | RXSIGHT, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| US-20240398551-A1 | LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR | RXSIGHT, INC. | 2024-12-05 | — | — | US | claimed |
| EP-4720136-A2 | LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR | RxSight, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024249726-A2 | LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR | RXSIGHT, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| US-20240398551-A1 | LIGHT ADJUSTABLE INTRAOCULAR LENSES WITH A CAGED PHOTOINITIATOR | RXSIGHT, INC. | 2024-12-05 | — | — | US | disclosed |
| US-7847110-B2 | Method for producing optionally substituted methylenedioxybenzene | RHODIA CHIMIE (FR) | 2010-12-07 | — | — | US | disclosed |
| EP-1737837-B1 | METHOD FOR PRODUCING OPTIONALLY SUBSTITUTED METHYLENEDIOXYBENZENE | RHODIA CHIMIE SA (FR) | 2008-02-27 | — | — | EP | disclosed |
| US-20080021228-A1 | Method For Producing Optionally Substituted Methylenedioxybenzene | RHODIA CHIMIE (FR) | 2008-01-24 | — | — | US | disclosed |
| EP-1737837-A1 | METHOD FOR PRODUCING OPTIONALLY SUBSTITUTED METHYLENEDIOXYBENZENE | RHODIA CHIMIE (FR) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005108385-A1 | METHOD FOR PRODUCING OPTIONALLY SUBSTITUTED METHYLENEDIOXYBENZENE | RHODIA CHIMIE (FR) | 2005-11-17 | — | — | WO | disclosed |
| US-4155915-A | POSTEMERGENCE AND PREEMERGENCE HERBICIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1979-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021228-A1 | Method For Producing Optionally Substituted Methylenedioxybenzene | COMT, INMT, DDT | MEN1 1461/4885KMT2A 125/4885LMNA 4497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.